Mattia Galli/LinkedIn
Oct 5, 2025, 08:21
Mattia Galli Gives a Talk on Pharma Pulse About “De-escalation” of Antiplatelet Therapy in ACS
Mattia Galli, Assistant Professor at Sapienza Università di Roma, Associate Editor of European Heart Journal, shared on LinkedIn:
”How far can we go with the “de-escalation” of antiplatelet therapy in patients with acute coronary syndrome?
We talk about it in our Pharma Pulse following the publication of the NEO-MINDSET trial.”
Read the full article in EHJ.
Article: Seeking for the boundaries of de-escalation in antiplatelet therapy for acute coronary syndrome
Authors: Mattia Galli, Felice Gragnano, Marco Valgimigli
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Oct 4, 2026, 15:06Vasiliki Gkalea: Journal of Clinical Medicine Launches Special Issue on Hematologic Thrombosis and Bleeding
-
Oct 4, 2026, 14:55Quentin Brebant: What Defines a High-Quality Red Blood Cell Concentrate?
-
Oct 4, 2026, 14:47Rana Al-Hrout: Recognizing Non-Anemic Iron Deficiency – Why Iron Matters Beyond Hemoglobin
-
Oct 4, 2026, 14:41David McIntosh: International Plasma Awareness Week 2026 – Closing the Global Plasma Gap
-
Oct 4, 2026, 14:33Pete Stibbs: CleanerVac Real-World Study Presented at VIVA and The VEINS 2026
-
Oct 4, 2026, 13:56Maria Elisa Mancuso: EHC 2026 Highlights the Unmet Needs of Women with Bleeding Disorders
-
Oct 4, 2026, 13:53Nirmal Shaji George: Individualizing Anticoagulation in Complex APS and Thrombocytopenia
-
Oct 4, 2026, 13:5210 Posts Not to Miss This Week
-
Oct 4, 2026, 13:45Suswapna Singh Rawat: The Clinical Significance of Coronary Plaque Stability